N-heterocyclic carbene metal complexes as therapeutic agents: a patent review

References

• Nelson DJ, Nolan SP. N‐heterocyclic carbenes, Ch. 1, in N‐Heterocyclic carbenes. Nolan SP Ed., Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim. 2014. p. 1–24.
   Google Scholar
• Jahnke MC, Hahn FE. Introduction to N-Heterocyclic carbenes: synthesis and stereoelectronic parameters, Ch. 1, in N-Heterocyclic carbenes: from laboratory curiosities to efficient synthetic tools: 2nd edition. Diez-Gonzalez S Ed. RSC Publishing: Cambridge, UK. 2016. p. 1–45.
   Google Scholar
• Hopkinson MN, Richter C, Schedler M, et al. An overview of N-heterocyclic carbenes. Nature. 2014;510:485–496.
   PubMed Web of Science ®Google Scholar
• Huynh HV. The organometallic chemistry of N‐heterocyclic carbenes, in Inorganic chemistry. Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim. 2017. p. 1–368.
   Google Scholar
• Smith CA, Narouz MR, Lummis PA, et al. N-heterocyclic carbenes in materials chemistry. Chem Rev. 2019;119:4986–5056.
   PubMed Web of Science ®Google Scholar
• Glorius F. N-heterocyclic carbenes in transition metal catalysis. Top Organomet Chem. 2007;21:1–232.
   Google Scholar
• Wang W, Cui L, Sun P, et al. Reusable N-heterocyclic carbene complex catalysts and beyond: a perspective on recycling strategies. Chem Rev. 2018;118:9843–9929.
   PubMed Web of Science ®Google Scholar
• Nelson DJ, Nolan SP. Quantifying and understanding the electronic properties of N-heterocyclic carbenes. Chem Soc Rev. 2013;42(16):6723–6753.
   PubMed Web of Science ®Google Scholar
• Huynh HV. Electronic properties of N-heterocyclic carbenes and their experimental determination. Chem Rev. 2018;118:9457–9492.
   PubMed Web of Science ®Google Scholar
• Velazquez HD, Verpoort F. N-heterocyclic carbene transition metal complexes for catalysis in aqueous media. Chem Soc Rev. 2012;41:7032–7060.
   PubMed Web of Science ®Google Scholar
• Schaper L-A, Hock SJ, Herrmann WA, et al. Synthesis and application of water‐soluble NHC transition‐metal complexes. Angew Chem Int Ed. 2013;52:270–289.
   PubMed Web of Science ®Google Scholar
• Oehninger L, Rubbiani R, Ott I. N-heterocyclic carbene metal complexes in medicinal chemistry. Dalton Trans. 2013;42:3269–3284.
   PubMed Web of Science ®Google Scholar
• Liu W, Gust R. Update on metal N-heterocyclic carbene complexes as potential anti-tumor metallodrugs. Coord Chem Rev. 2016;329:191–213.
   Web of Science ®Google Scholar
• Patil SA, Patil SA, Patil R, et al. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs. Future Med Chem. 2015;7:1305–1333.
   PubMed Web of Science ®Google Scholar
• Patil SA, Hoagland AP, Patil SA, et al. N-heterocyclic carbene-metal complexes as bio-organometallic antimicrobial and anticancer drugs, an update (2015–2020). Future Med Chem. 2020;12:2239–2275.
   PubMed Web of Science ®Google Scholar
• Kascatan-Nebioglu A, Panzner MJ, Tessier CA, et al. N-Heterocyclic carbene–silver complexes: a new class of antibiotics. Coord Chem Rev. 2007;251:884–895.
   Web of Science ®Google Scholar
• Budagumpi S, Haque RA, Endud S, et al. Biologically relevant Silver(I)-N-Heterocyclic carbene Complexes: synthesis, structure, intramolecular interactions, and applications. Eur J Inorg Chem. 2013;4367–4388.
   Google Scholar
• Johnson NA, Southerland MR, Youngs WJ. Recent developments in the medicinal applications of silver-NHC complexes and imidazolium salts. Molecules. 2017;22(8):1263.
   Web of Science ®Google Scholar
• Dominelli B, Correia JDG, Kühn FE. Medicinal applications of gold(I/III)-based complexes bearing N-heterocyclic carbene and phosphine ligands. J Organomet Chem. 2018;866:153–164.
   Web of Science ®Google Scholar
• Mora M, Concepción Gimeno M, Visbal R. Recent advances in gold–NHC complexes with biological properties. Chem Soc Rev. 2019;48:447–462.
   PubMed Web of Science ®Google Scholar
• Tong K-C, Hu D, Wan P-K, et al. Anticancer gold(III) compounds with porphyrin or N-heterocyclic carbene ligands. Front Chem. 2020. DOI:https://doi.org/10.3389/fchem.2020.587207
   Google Scholar
• Bellemin-Laponnaz S. N-heterocyclic carbene platinum complexes: a big step forward for effective antitumor compounds. Eur J Inorg Chem. 2020;10–20. DOI:https://doi.org/10.1002/ejic.201900960
   Google Scholar
• Zou T, Lok C-N, Wan P-K, et al. Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium. Curr Opin Chem Biol. 2018;43:30–36.
   PubMed Web of Science ®Google Scholar
• Faivre-Chauvet A, Rajaerison H, Gestin J-F Radioactive rhodium complexes, preparation methods and uses thereof. US 2015/0139901 A1. 2015.
   Google Scholar
• Kuehl O. Imidazolium salts and carbene metal complexes based thereon for use as bioanalytical markers for biomolecules. US 9,150,515 B2. 2015.
   Google Scholar
• Rosenberg B, Van Camp L, Krigas T. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature. 1965;205:698–699.
   Google Scholar
• Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin−DNA adducts. Chem Rev. 1999;99:2467–2498.
   PubMed Web of Science ®Google Scholar
• Ott I, Gust R. Preclinical and clinical studies on the use of platinum complexes for breast cancer treatment. Anticancer Agents Med Chem. 2007;7:95–110.
   PubMed Web of Science ®Google Scholar
• Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov. 2005;4:307–320.
   PubMed Web of Science ®Google Scholar
• Wheate NJ, Walker S, Craig GE, et al. The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Trans. 2010;39:8113–8127.
   PubMed Web of Science ®Google Scholar
• Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 2007;33:9–23.
   PubMed Web of Science ®Google Scholar
• Che C, Zou T. Novel gold(III) complexes containing N-heterocyclic carbene ligand, synthesis, and their applications in cancer treatment and thiol detection. WO 2014/075394 Al. 2014.
   Google Scholar
• Che C, Zou T. A method of using binuclear gold(I) compounds for cancer treatment. WO 2014/075574 Al. 2014.
   Google Scholar
• Altaf M, Isab AA. N-heterocyclic carbene gold complexes with anticancer properties and methods of use thereof. US 2016/0326187 A1. 2016.
   Google Scholar
• Veige AS, Garner ME, Niu W. Aptamer conjugates with N-heterocyclic carbene metal complexes for targeted drug delivery. US 2017/0107516 A1. 2017.
   Google Scholar
• Sulaiman AAA, Altaf M, Isab AA. Gold(I) complexes, pharmaceutical compositions thereof, and methods of treating proliferative disorders. US 10,189,865 B1. 2019.
   Google Scholar
• Sulaiman AAA, Altaf M, Isab AA. Method for treating cancer using a selenourea-coordinated gold(I)-carbene complex. US 2019/0125757 A1. 2019.
   Google Scholar
• Isab AA, Sulaiman AAA. Method of treating cancer and other proliferative diseases with a gold(I) complex. US 10,544,165 B1. 2020.
   Google Scholar
• Che CM, Sun RWY, Chow LF, et al. Pharmaceutical composition containing cyclometallated N-heterocyclic carbene complexes for cancer treatment. US 2011/0098264 A1. 2011.
   Google Scholar
• Sessler JL, Sen S, Arambula JF, et al. Functionalized gold carbene naphthoquinone complexes for use in the treatment of cancer. WO 2020/237225. 2020.
   Google Scholar
• Che CM, Lam TL, Tong KC. Iridium(III) complexes containing N-heterocyclic carbene ligand, synthesis, and their use thereof in cancer treatment. WO 2020/024969 Al. 2020.
   Google Scholar
• Che CM, Fung SK, Chen TF. Platinum(II) complexes containing N-heterocyclic carbene ligand and pincer ligands, synthesis, and their applications in cancer treatment. US 2020/0048291 Al. 2020.
   Google Scholar
• Sarkar A, Mandal SW. Lipid-based platinum-N-heterocyclic carbene compounds and nanoparticles. WO 2014/199352. 2014.
   Google Scholar
• Kumar A, Naaz A, Palanisamy PA, et al. Anticancer property studies of chiral palladium N-heterocyclic carbene complexes and process for preparation thereof. US 2018/0194789 A1. 2018.
   Google Scholar
• Che CM, Fong TH, Lok CN, et al. Palladium(II) complexes containing N-heterocyclic carbene ligand, synthesis, and applications in cancer treatment. WO 2018/028453 A1. 2018.
   Google Scholar
• Visentin F, Scattolin T, Bortolamiol E, et al. Pd(I) complexes, process for their preparation and use thereof as antitumour agents. WO 2021/110790 A1. 2021.
   Google Scholar
• Lansdown ABG, Silver I. Its antibacterial properties and mechanism of action. J Wound Care. 2002;11:125–130.
   PubMedGoogle Scholar
• Drousou A, Falabella A, Kirsner RS. Antiseptics on wounds: an area of controversy. Wounds. 2003;15:149–166.
   Web of Science ®Google Scholar
• Youngs W, Panzner MJ, Cannon CL. Metal complexes of N-heterocyclic carbenes. WO 2012/050629 A1. 2012.
   Google Scholar
• Youngs W, Panzner MJ, Cannon CL. Metal complexes of N-heterocyclic carbenes. US 2011/0086830 A1. 2011.
   Google Scholar
• Leeper T, Panzner M, Youngs W, et al. Silver based gels for antimicrobial applications. WO 2013/130922 A2. 2013.
   Google Scholar
• Bera JK, Chopra S, Matheshwaran S, et al. Antibacterial platinum N-heterocyclic carbene compounds and process of preparation thereof. IN 201911025087. 2019.
   Google Scholar
• Metzler-Nolte N, Siegmund D, Bandow J, et al. EF-TU-binding metal-containing antibiotic. US 2020/0199162 A1. 2020.
   Google Scholar